MeSH D016920 - bacterial meningitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008581:Meningitis
0 Companies
0 Drugs
Success rate
D020806:Central nervous system bacterial infections
0 Companies
0 Drugs
Success rate
D016920:Â
Bacterial meningitis
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Avibactam, Ceftazidime | Avycaz | 2026-01-07 | 2015-02-25 | $98.8 M | Q2/19-Q1/20 |
| Prednisolone, Neomycin, Polymyxin b | Poly-pred |  | 1982-01-01 |  |  | |
| Nafcillin | Nafcillin |  | 1988-10-26 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Otocort |  | 1982-01-01 |  |  | |
| Altana | Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Bacitracin-neomycin-polymyxin W/ Hydrocortisone |  | 1982-01-01 |  |  |
| Amring Pharmaceuticals | Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 2005-10-31 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
93%14/15
Approved: 12Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use